Physician profile
Misty D Thomas
NPI 1356079875
$650.62
in general payments reported to CMS, 2019-2025
13 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $223 · 2024: $160 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $650.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $147.33 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Abbvie INC. | $107.80 | 2023-2025 | |
| Novo Nordisk INC | $69.49 | 2024-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $69.28 | 2024-2025 | |
| Seqirus USA INC | $55.89 | 2023-2025 | Flucelvax, Fluad, Flucelvax Quadrivalent |
| Sanofi-Aventis U.S. LLC | $38.98 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $30.56 | 2023-2025 | Nexium, Breztri |
| Exact Sciences Corporation | $28.57 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $28.23 | 2023 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $21.79 | 2023 | |
| Merck Sharp & Dohme LLC | $20.42 | 2023 | Vaxneuvance, M-M-R II, Gardasil 9 |
| Inari Medical, INC. | $18.35 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Organon LLC | $13.93 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Misty Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.